GI Dynamics Announces Promising Multi-Center Safety And Efficacy Data Of EndoBarrier? Gastrointestinal Liner For Pre-Surgical Weight Loss

GI Dynamics, a medical device company pioneering the development of new approaches to treat obesity and metabolic disorders, today announced new data regarding the EndoBarrier?, its novel, noninvasive device currently in clinical trials to treat obesity and type 2 diabetes. New data from a multi-center, randomized clinical trial indicate that the EndoBarrier is a safe, noninvasive device with excellent short-term weight loss results in morbidly obese patients.

More: continued here

Filed under: Diabetes on October 1st, 2008